Pharmaceutical Industry
🇺🇸 FDAFDA news and analysis for pharmaceutical BD, investment, and market access
Unlock global pharmaceutical market intelligence. Stay ahead with expert analysis on drug development, regulatory affairs, and M&A trends for pharma BD.
Showing 1–12 of 27 articles
Quick answer
NovaPharmaNews Pharmaceutical Industry hub for FDA covers 27 published articles — news and analysis for pharma BD, investors, and market access teams. Browse related topics below or explore companies, pipeline, and events linked from each story.
Biosimilars Drive Significant Reductions in Specialty Drug Spending
EU Publishes Roadmap to Reduce Animal Testing: Implications for Pharma
Medicare's GLP-1 Stance and UnitedHealthcare Lawsuit: Key Implications for Pharma
ASCO 2026: Grief Takes Center Stage Amidst Cancer Data
CMS Finalizes Medicaid Work Requirement Rules, Impacting State Programs and Pharma Strategy
FSMA Final Rule: New Traceability Requirements Impacting Food Safety
5 FDA Drug Approvals to Watch in 2026
Research Progress and Development Strategies of Antibody-Oligonucleotide Conjugates
Sen. Dick Durbin: Trump is Letting Big Tobacco Target Children
Astellas Cuts Costs Amid FDA Review of Moderna Vaccine
Understanding the Financial Implications of STAT+: $775 Billion, $1.2 Billion, and $38K
Lantheus Considers $7B Acquisition of Curium: Implications for Pharma
Frequently asked questions
How often is this topic updated?
New articles are published continuously as regulatory, clinical, and commercial signals break. Use the content-type filters for latest news vs in-depth analysis.
Where does this coverage come from?
Editorial intelligence combines FDA openFDA, ClinicalTrials.gov, SEC EDGAR, congress calendars, and analyst reporting. See our data sources policy for attribution.